E-LIB Suche - Ergebnisse für: Rein, Lindsay A.M.

1

Initial Results from Summit: An On-going, 3-Part, Multi-Cen..:

Modena, Brian ; Rein, Lindsay A.M. ; Oh, Stephen...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB224 , 2024

Link: https://doi.org/10.1016/..

2

The Use of Allogeneic Hematopoietic Stem Cell Transplantati..:

Wolfe, Heather R. ; Horwitz, Mitchell E. ; Rein, Lindsay A. M.
Journal of Personalized Medicine. 12 (2022) 4 - p. 571 , 2022

Link: https://doi.org/10.3390/..

3

Leveraging Natural Killer Cell Innate Immunity against Hema..:

Lin, Chenyu ; Horwitz, Mitchell E. ; Rein, Lindsay A. M.
International Journal of Molecular Sciences. 24 (2022) 1 - p. 204 , 2022

Link: https://doi.org/10.3390/..

4

The Evolving Landscape of Frontline Therapy in Chronic Phas..:

Wolfe, Heather R. ; Rein, Lindsay A. M.
Current Hematologic Malignancy Reports. 16 (2021) 5 - p. 448-454 , 2021

Link: https://doi.org/10.1007/..

5

Applications of Gene Editing Technologies to Cellular Thera..:

Rein, Lindsay A.M. ; Yang, Haeyoon ; Chao, Nelson J.
Biology of Blood and Marrow Transplantation. 24 (2018) 8 - p. 1537-1545 , 2018

Link: https://doi.org/10.1016/..

6

Clinical potential of elacytarabine in patients with acute ..:

Rein, Lindsay A. M. ; Rizzieri, David A.
Therapeutic Advances in Hematology. 5 (2014) 6 - p. 211-220 , 2014

Link: https://doi.org/10.1177/..

7

POSTER: MPN-524 Reductions in Indolent Systemic Mastocytosi..:

Gotlib, Jason ; Castells, Mariana ; Elberink, Hanneke Oude...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S194 , 2023

Link: https://doi.org/10.1016/..

8

MPN-524 Reductions in Indolent Systemic Mastocytosis Biomar..:

Gotlib, Jason ; Castells, Mariana ; Elberink, Hanneke Oude...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S398-S399 , 2023

Link: https://doi.org/10.1016/..

9

Randomized Phase 3 Trial of Ruxolitinib for COVID-19–Associ..:

Rein, Lindsay ; Calero, Karel ; Shah, Ronak...
Critical Care Medicine. 50 (2022) 12 - p. 1701-1713 , 2022

Link: https://doi.org/10.1097/..

10

β-Arrestin2 mediates progression of murine primary myelofib..:

Rein, Lindsay A.M ; Wisler, James W ; Kim, Jihee...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752278/. , 2017

Link: http://www.ncbi.nlm.nih...

11

Clinical potential of elacytarabine in patients with acute ..:

Rein, Lindsay A. M ; Rizzieri, David A
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

12

Leveraging Natural Killer Cell Innate Immunity against Hema..:

Chenyu Lin ; Mitchell E. Horwitz ; Lindsay A. M. Rein
https://www.mdpi.com/1422-0067/24/1/204. , 2022

Link: https://doi.org/10.3390/..

13

The Use of Allogeneic Hematopoietic Stem Cell Transplantati..:

Heather R. Wolfe ; Mitchell E. Horwitz ; Lindsay A. M. Rein
https://www.mdpi.com/2075-4426/12/4/571. , 2022

Link: https://doi.org/10.3390/..

14

The Use of Allogeneic Hematopoietic Stem Cell Transplantati..:

Heather R. Wolfe ; Mitchell E. Horwitz ; Lindsay A. M. Rein
Clinical Medicine, Cell, and Organism Physiology. , 2022

Link: https://doi.org/10.3390/..

15

Leveraging Natural Killer Cell Innate Immunity against Hema..:

Chenyu Lin ; Mitchell E. Horwitz ; Lindsay A. M. Rein
Molecular Pathology, Diagnostics, and Therapeutics. , 2022

Link: https://doi.org/10.3390/..